Tropicamide Ophthalmic Solution, USP

Manufacturer
REMEDYREPACK INC.
Effective date
2019-07-25
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 00:18:04

Label at a glance#

ProductTropicamide
Active ingredientTROPICAMIDE
Label structure11 sections

Indications and uses

For mydriasis and cycloplegia for diagnostic procedures.

Dosage and administration

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

DESCRIPTION:

DESCRIPTION SECTION

Tropicamide Ophthalmic Solution, USP is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths. The active ingredient is represented by the structural formula:

Structural Formula
Structural Formula

C 17H 20N 2O 2         MW=284.36

Established name: Tropicamide

Chemical name: Benzeneacetamide, N-ethyl-α-(hydroxymethyl)- N-(4-pyridinylmethyl)-.

Each mL contains: Active: Tropicamide 0.5% (5 mg) or 1% (10 mg). Inactives: Edetate Disodium, Sodium Chloride, Hydrochloric Acid and/or Sodium Hydroxide (to adjust pH), Water for Injection. pH range 4.0 to 5.8. Preservative: Benzalkonium Chloride 0.01%.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation, dilating the pupil (mydriasis). The stronger preparation (1%) also paralyzes accommodation. This preparation acts in 15-30 minutes and the duration of activity is approximately 3-8 hours. Complete recovery from mydriasis in some individuals may require 24 hours. The weaker strength may be useful in producing mydriasis with only slight cycloplegia. Heavily pigmented irides may require more doses than lightly pigmented irides.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

For mydriasis and cycloplegia for diagnostic procedures.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Contraindicated in persons showing hypersensitivity to any component of this preparation.

WARNINGS:

WARNINGS SECTION

For topical use only — not for injection.

This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered.

Mydriatics may produce a transient elevation of intraocular pressure.

Remove contact lenses before using.

PRECAUTIONS:

PRECAUTIONS SECTION

GENERAL PRECAUTIONS SECTION

General: The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to avoid excessive systemic absorption.

INFORMATION FOR PATIENTS SECTION

Information for Patients: Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in potentially hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration.

DRUG INTERACTIONS SECTION

Drug Interactions: Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility: There have been no long-term studies done using tropicamide in animals to evaluate carcinogenic potential.

PREGNANCY SECTION

Pregnancy: Pregnancy Category C. Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS SECTION

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.

PEDIATRIC USE SECTION

Pediatric Use: Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (See WARNINGS). Keep this and all medications out of the reach of children.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

SPL UNCLASSIFIED SECTION

Ocular: Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydri-atics.

SPL UNCLASSIFIED SECTION

Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.

HOW SUPPLIED:

HOW SUPPLIED SECTION

Tropicamide Ophthalmic Solution USP, 0.5% and 1% are supplied as sterile solutions in plastic dropper bottles.

  • 0.5%   NDC 17478-101-12 (15 mL)
  • 1%      NDC 17478-102-12 (15 mL)
  • 1%      NDC 17478-102-20 (2 mL)

STORAGE AND HANDLING SECTION

STORAGE: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Do not refrigerate or store at high temperatures. Keep container tightly closed.

Akorn

Manufactured by: Akorn, Inc.
Lake Forest, IL 60045
TC00N Rev. 10/16

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DRUG: Tropicamide

GENERIC: Tropicamide

DOSAGE: SOLUTION/ DROPS

ADMINSTRATION: OPHTHALMIC

NDC: 70518-0744-0

PACKAGING: 15 mL in 1 BOTTLE, DROPPER

OUTER PACKAGING: 1 in 1 CARTON

ACTIVE INGREDIENT(S):

  • Tropicamide 10mg in 1mL

INACTIVE INGREDIENT(S):

  • benzalkonium chloride
  • hydrochloric acid
  • sodium hydroxide
  • edetate disodium
  • sodium chloride
  • water

Remedy_LabelRemedy_Label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17478-102-12ML - Milliliter17478-102a40716e4-abb9-40f2-9f35-a8165d94b39512012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70518-074470518-0744-0
17478-102

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040315-001TROPICACYLTROPICAMIDE1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A040315-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2984e616aacf4f…
2026-08-18 06:07:402026-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f01610625f2…
2019-09-15 20:21 UTC2019-09A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-293a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040315-001TROPICACYL1%SOLUTION/DROPS / OPHTHALMICAT2000-09-29f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A040315-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A040315-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A040315-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A040315-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A040315-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A040315-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A040315-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A040315-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A040315-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A040315-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A040315-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A040315-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A040315-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A040315-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A040315-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A040315-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A040315-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A040315-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A040315-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A040315-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A040315-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A040315-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A040315-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A040315-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A040315-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A040315-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A040315-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A040315-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A040315-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A040315-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A040315-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A040315-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A040315-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A040315-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A040315-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A040315-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A040315-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A040315-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A040315-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A040315-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a4d670a3-390d-8296-e053-2a95a90a73ed17a9cfbc-d212-4e27-8552-b65df2b70a2d2020-05-04Warnings, Adverse reactionsExact identifier
spl set id: 17a9cfbc-d212-4e27-8552-b65df2b70a2d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.